{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:33:56Z","timestamp":1793093636547,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119348","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T08:26:59Z","timestamp":1775896019000},"page":"119348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3177-989X","authenticated-orcid":false,"given":"Carl P.","family":"Soltau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-8001","authenticated-orcid":false,"given":"Ban Qi","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Bottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119348_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2026.119348_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.biopha.2026.119348_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/1120009X.2023.2300217","article-title":"Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents","volume":"36","author":"Manavi","year":"2024","journal-title":"J. Chemother."},{"key":"10.1016\/j.biopha.2026.119348_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.2012.581","article-title":"Cancer heterogeneity: implications for targeted therapeutics","volume":"108","author":"Fisher","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2026.119348_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020280","article-title":"Dynamic cancer cell heterogeneity: diagnostic and therapeutic implications","volume":"14","author":"Jacquemin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119348_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12032-025-02812-3","article-title":"Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies","volume":"42","author":"Yusoh","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119348_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092073","article-title":"Platinum complexes in colorectal cancer and other solid tumors","volume":"13","author":"Koberle","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119348_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862743","article-title":"The relationship of redox with hallmarks of cancer: the importance of homeostasis and context","volume":"12","author":"Xing","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119348_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6235641","article-title":"Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy","volume":"2016","author":"Marengo","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2026.119348_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119348_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2016.03.006","article-title":"Platinum anti-cancer drugs: free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect","volume":"95","author":"Fong","year":"2016","journal-title":"Free Radiac. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119348_bib14","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4252\/wjsc.v12.i11.1410","article-title":"Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells","volume":"12","author":"Jagust","year":"2020","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2026.119348_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/972913","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Traverso","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2026.119348_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119348_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112490","article-title":"Nitroxides as antioxidants and anticancer drugs","volume":"18","author":"Lewandowski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119348_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031446","article-title":"The cellular and organismal effects of nitroxides and nitroxide-containing nanoparticles","volume":"25","author":"Sadowska-Bartosz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119348_bib19","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1038\/s41598-021-94340-z","article-title":"Tempol differently affects cellular redox changes and antioxidant enzymes in various lung-related cells","volume":"11","author":"Park","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119348_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2026.119348_bib21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/cbt.12.8.16441","article-title":"Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells","volume":"12","author":"Cheng","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2026.119348_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/CAD.0b013e32836442c6","article-title":"Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma","volume":"24","author":"Dilip","year":"2013","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2026.119348_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbi.2012.06.001","article-title":"Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line","volume":"199","author":"Guo","year":"2012","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.biopha.2026.119348_bib24","first-page":"1271","article-title":"Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo","volume":"6","author":"Sun","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119348_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0891-5849(00)00347-6","article-title":"The nitroxide tempol induces oxidative stress, p21(WAF1\/CIP1), and cell death in HL60 cells","volume":"29","author":"Gariboldi","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib26","first-page":"3289","article-title":"Synthesis of anti-oxidant steroids by hybridisation with nitroxides","volume":"56","author":"Soltau","year":"2023","journal-title":"Synthesis"},{"key":"10.1016\/j.biopha.2026.119348_bib27","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/j.bmc.2014.09.035","article-title":"Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents","volume":"22","author":"Zhao","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119348_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.freeradbiomed.2010.02.009","article-title":"Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells","volume":"48","author":"Selvendiran","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib29","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00044-013-0906-8","article-title":"Synthesis of novel spin-labeled derivatives of 5-FU as potential antineoplastic agents","volume":"23","author":"Yang","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.biopha.2026.119348_bib30","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119348_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/1568026616666160927155515","article-title":"Hybrid compounds as multitarget directed anticancer agents","volume":"17","author":"Kucuksayan","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2026.119348_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16070889","article-title":"Recent advances in the development of hybrid drugs","volume":"16","author":"Morais","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119348_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107933","article-title":"Steroid and bioactive molecule conjugates: Improving therapeutic approaches in disease management","volume":"153","author":"Kawka","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.119348_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsbiomedchemau.1c00071","article-title":"A comprehensive review on steroidal bioconjugates as promising leads in drug discovery","volume":"2","author":"Bansal","year":"2022","journal-title":"ACS Bio Med Chem. Au"},{"key":"10.1016\/j.biopha.2026.119348_bib35","article-title":"Redox-active nitroxides enhance cisplatin efficacy against cervical cancer","author":"Soltau","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119348_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.biopha.2026.119348_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s42003-021-02136-8","article-title":"Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy","volume":"4","author":"Kildey","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.biopha.2026.119348_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF01221192","article-title":"Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin","volume":"122","author":"Otto","year":"1996","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119348_bib39","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/cbt.12.8.16441","article-title":"Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells","volume":"12","author":"Cheng","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2026.119348_bib40","first-page":"4847","article-title":"Piperidine nitroxide Tempol enhances cisplatin-induced apoptosis in ovarian cancer cells","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2026.119348_bib41","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/acsomega.3c07624","article-title":"Antiproliferative and apoptotic effects of tempol, methotrexate, and their combinations on the MCF7 breast cancer cell line","volume":"9","author":"Kaplan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2026.119348_bib42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0891-5849(97)00372-9","article-title":"Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines","volume":"24","author":"Gariboldi","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pros.24473","article-title":"Tempol differential effect on prostate cancer inflammation: In vitro and in vivo evaluation","volume":"83","author":"Rossetto","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.biopha.2026.119348_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0167-4889(86)90073-X","article-title":"Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell\/nitroxide ratio, oxygen concentrations and permeability of nitroxides","volume":"888","author":"Swartz","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2026.119348_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071683","article-title":"Glucocorticoid Receptor (GR) expression in human tumors: a tissue microarray study on more than 14,000 tumors","volume":"13","author":"Tsourlakis","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119348_bib46","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biopha.2026.119348_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0253-7613.62412","article-title":"Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study","volume":"42","author":"Surendiran","year":"2010","journal-title":"Indian. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119348_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108889","article-title":"Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice","volume":"9","author":"Ahmed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2026.119348_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0891-5849(03)00306-X","article-title":"Pro-oxidative activity of nitroxides in their reactions with glutathione","volume":"35","author":"Glebska","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.taap.2008.10.014","article-title":"Cisplatin upregulates mitochondrial nitric oxide synthase and peroxynitrite formation to promote renal injury","volume":"234","author":"Jung","year":"2009","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.biopha.2026.119348_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.redox.2016.10.016","article-title":"Targeting nitrative stress for attenuating cisplatin-induced downregulation of cochlear LIM domain only 4 and ototoxicity","volume":"10","author":"Jamesdaniel","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119348_bib52","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cncr.20898","article-title":"Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice","volume":"103","author":"Suy","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2026.119348_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations","volume":"52","author":"Kalyanaraman","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119348_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118655","article-title":"Structure-activity relationship of steroidal-nitroxide hybrids: dual-modulators of glucocorticoid receptor signalling and cellular redox state","volume":"307","author":"Soltau","year":"2026","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:34:38Z","timestamp":1779244478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226003811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":54,"alternative-id":["S0753332226003811"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119348","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroidal-nitroxide hybrid sustains oxidative stress and enhances cisplatin efficacy in vitro across multiple cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119348"}}